Bioteque Corporation (4107.TWO)
TWD 120.0
(-1.23%)
TWD 120.0
(-1.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 736.13 Million TWD | -3.03% |
| 2022 | 759.12 Million TWD | 14.62% |
| 2021 | 662.29 Million TWD | -7.36% |
| 2020 | 714.92 Million TWD | 3.52% |
| 2019 | 690.63 Million TWD | 14.32% |
| 2018 | 604.13 Million TWD | 27.22% |
| 2017 | 471.85 Million TWD | -8.97% |
| 2016 | 517.43 Million TWD | 9.33% |
| 2015 | 441.13 Million TWD | 17.62% |
| 2014 | 405.67 Million TWD | 26.98% |
| 2013 | 304.76 Million TWD | 27.31% |
| 2012 | 290.16 Million TWD | 23.65% |
| 2011 | 204.32 Million TWD | -20.7% |
| 2010 | 256.94 Million TWD | 14.03% |
| 2009 | 225.77 Million TWD | -3.31% |
| 2008 | 226.37 Million TWD | 283.6% |
| 2007 | 460.45 Million TWD | -47.17% |
| 2006 | 118.23 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 191.5 Million TWD | 6.74% |
| 2024 Q1 | 179.41 Million TWD | -12.96% |
| 2023 Q1 | 165.23 Million TWD | -9.29% |
| 2023 Q2 | 176.61 Million TWD | 6.89% |
| 2023 FY | - TWD | -3.03% |
| 2023 Q4 | 206.12 Million TWD | -6.19% |
| 2023 Q3 | 219.71 Million TWD | 24.4% |
| 2022 Q2 | 190.77 Million TWD | 5.63% |
| 2022 Q4 | 182.16 Million TWD | -11.39% |
| 2022 Q1 | 180.61 Million TWD | -0.13% |
| 2022 FY | - TWD | 14.62% |
| 2022 Q3 | 205.57 Million TWD | 7.76% |
| 2021 Q4 | 180.84 Million TWD | 19.72% |
| 2021 Q1 | 183.95 Million TWD | -8.12% |
| 2021 FY | - TWD | -7.36% |
| 2021 Q2 | 146.43 Million TWD | -20.39% |
| 2021 Q3 | 151.06 Million TWD | 3.16% |
| 2020 FY | - TWD | 3.52% |
| 2020 Q1 | 164.31 Million TWD | 1.71% |
| 2020 Q4 | 200.21 Million TWD | 9.78% |
| 2020 Q3 | 182.37 Million TWD | 8.53% |
| 2020 Q2 | 168.03 Million TWD | 2.26% |
| 2019 FY | - TWD | 14.32% |
| 2019 Q2 | 194.86 Million TWD | 16.18% |
| 2019 Q1 | 167.71 Million TWD | 0.25% |
| 2019 Q4 | 161.54 Million TWD | -2.98% |
| 2019 Q3 | 166.5 Million TWD | -14.55% |
| 2018 FY | - TWD | 27.22% |
| 2018 Q3 | 141.45 Million TWD | -15.99% |
| 2018 Q4 | 167.29 Million TWD | 18.27% |
| 2018 Q1 | 126.99 Million TWD | -3.87% |
| 2018 Q2 | 168.38 Million TWD | 32.6% |
| 2017 Q4 | 132.11 Million TWD | -0.18% |
| 2017 Q1 | 77.78 Million TWD | -40.62% |
| 2017 Q3 | 132.34 Million TWD | 0.3% |
| 2017 FY | - TWD | -8.97% |
| 2017 Q2 | 131.94 Million TWD | 69.63% |
| 2016 Q2 | 142.48 Million TWD | 9.48% |
| 2016 Q3 | 118.06 Million TWD | -17.14% |
| 2016 Q4 | 130.98 Million TWD | 10.95% |
| 2016 FY | - TWD | 9.33% |
| 2016 Q1 | 130.15 Million TWD | 15.44% |
| 2015 FY | - TWD | 17.62% |
| 2015 Q1 | 104.06 Million TWD | -13.22% |
| 2015 Q4 | 112.73 Million TWD | -20.97% |
| 2015 Q2 | 117.68 Million TWD | 13.08% |
| 2015 Q3 | 142.65 Million TWD | 21.22% |
| 2014 Q4 | 119.92 Million TWD | 13.86% |
| 2014 FY | - TWD | 26.98% |
| 2014 Q3 | 105.33 Million TWD | 9.08% |
| 2014 Q2 | 96.56 Million TWD | 15.16% |
| 2014 Q1 | 83.85 Million TWD | 4.58% |
| 2013 Q4 | 80.17 Million TWD | -7.77% |
| 2013 FY | - TWD | 27.31% |
| 2013 Q1 | 71.63 Million TWD | 9.77% |
| 2013 Q2 | 80.73 Million TWD | 12.7% |
| 2013 Q3 | 86.93 Million TWD | 7.67% |
| 2012 Q2 | 61.01 Million TWD | 4.67% |
| 2012 Q1 | 58.28 Million TWD | -13.0% |
| 2012 Q3 | 67.94 Million TWD | 11.37% |
| 2012 FY | - TWD | 23.65% |
| 2012 Q4 | 65.26 Million TWD | -3.95% |
| 2011 Q2 | 46.91 Million TWD | -0.34% |
| 2011 Q1 | 47.07 Million TWD | -14.31% |
| 2011 FY | - TWD | -20.7% |
| 2011 Q3 | 41.96 Million TWD | -10.56% |
| 2011 Q4 | 66.99 Million TWD | 59.66% |
| 2010 Q4 | 54.93 Million TWD | -23.05% |
| 2010 Q3 | 71.39 Million TWD | 6.78% |
| 2010 Q2 | 66.85 Million TWD | 6.54% |
| 2010 Q1 | 62.75 Million TWD | 0.0% |
| 2010 FY | - TWD | 14.03% |
| 2009 FY | - TWD | -3.31% |
| 2008 FY | - TWD | 283.6% |
| 2007 FY | - TWD | -47.17% |
| 2006 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 1.01 Billion TWD | 27.19% |
| Chi Sheng Pharma & Biotech Co., Ltd | 117.55 Million TWD | -526.222% |
| Sunder Biomedical Tech. Co., Ltd. | 76.61 Million TWD | -860.85% |
| BenQ Medical Technology Corporation | 532.15 Million TWD | -38.332% |
| Pacific Hospital Supply Co., Ltd | 673.8 Million TWD | -9.251% |
| Unicon Optical Co., Ltd. | 377.24 Million TWD | -95.133% |
| Formosa Optical Technology Co.,Ltd. | 1.04 Billion TWD | 29.588% |
| Medeon Biodesign, Inc. | -1.14 Billion TWD | 164.465% |
| Concord Medical Co., Ltd. | 137.47 Million TWD | -435.473% |
| Crystalvue Medical Corporation | 149.73 Million TWD | -391.639% |
| Perfect Medical Industry Co., Ltd. | 115.48 Million TWD | -537.458% |
| ICARES Medicus, Inc. | 165.54 Million TWD | -344.685% |
| Lagis Enterprise Co., Ltd. | 112.36 Million TWD | -555.135% |
| Amed Co., Ltd. | 157.32 Million TWD | -367.905% |